Odyssey Health (ODYY) Shareholder's Equity Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) Shareholder's Equity Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -25.45% |
| Oct 31, 2025 | -9.95% |
| Jul 31, 2025 | -14.41% |
| Apr 30, 2025 | -18.00% |
| Jan 31, 2025 | -15.66% |
| Oct 31, 2024 | -27.97% |
| Jul 31, 2024 | -24.45% |
| Apr 30, 2024 | 117.73% |
| Jan 31, 2024 | 119.21% |
| Oct 31, 2023 | -124.44% |
| Jul 31, 2023 | -111.41% |
| Apr 30, 2023 | -67.96% |
| Jan 31, 2023 | -73.61% |
| Oct 31, 2022 | -83.13% |
| Jul 31, 2022 | -98.49% |
| Apr 30, 2022 | -60.88% |
| Jan 31, 2022 | -65.41% |
| Oct 31, 2021 | -49.93% |
| Jul 31, 2021 | -50.04% |
| Apr 30, 2021 | -7.89% |